| Symbol | OVID |
|---|---|
| Name | OVID THERAPEUTICS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 1460 BROADWAY,SUITE 15021, NEW YORK, New York, 10036, United States |
| Telephone | +1 646 661-7661 |
| Fax | — |
| — | |
| Website | https://www.ovidrx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001636651 |
| Description | Ovid Therapeutics Inc is a biopharmaceutical company. The firm is primarily engaged in developing impactful medicines for patients and families living who are suffering from epilepsies, seizure-related disorders, and neurological disorders. It is targeting disorders such as intellectual disability, severe speech impairment, problems with movement and balance, sleep disorders and anxiety to transform the patients life. Additional info from NASDAQ: |
Ovid Therapeutics Inc. - Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
Read moreOvid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
Read moreNew Form SCHEDULE 13G/A - Ovid Therapeutics Inc. <b>Filed:</b> 2026-07-08 <b>AccNo:</b> 0001623632-26-000990 <b>Size:</b> 45 KB
Read moreGreka Anna 🟢 acquired 130.0K shares (1 derivative) of Ovid Therapeutics Inc. (OVID) at $2.26 Transaction Date: Jun 15, 2026 | Filing ID: 000005
Read moreNew Form 3 - Ovid Therapeutics Inc. <b>Filed:</b> 2026-06-17 <b>AccNo:</b> 0002138163-26-000003 <b>Size:</b> 8 KB
Read moreOvid Therapeutics Inc. - Ovid Therapeutics to Participate in Upcoming Investor Conferences
Read more(99% Neutral) OVID THERAPEUTICS INC. (OVID) Announces New Board Appointment
Read moreOvid Therapeutics Inc. - Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
Read more